APA

Gupta A., Pal S. K., Pandey D., Fakir N. A., Rathod S., Sinha D., SivaKumar S., Sinha P., Periera M., Balgam S., Sekar G., UmaDevi K. R., Anupurba S. & Nema V. (20180328). PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis. : Annals of clinical microbiology and antimicrobials.

Chicago

Gupta Anamika, Pal Sudhir K, Pandey Divya, Fakir Najneen A, Rathod Sunita, Sinha Dhiraj, SivaKumar S, Sinha Pallavi, Periera Mycal, Balgam Shilpa, Sekar Gomathi, UmaDevi K R, Anupurba Shampa and Nema Vijay. 20180328. PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis. : Annals of clinical microbiology and antimicrobials.

Harvard

Gupta A., Pal S. K., Pandey D., Fakir N. A., Rathod S., Sinha D., SivaKumar S., Sinha P., Periera M., Balgam S., Sekar G., UmaDevi K. R., Anupurba S. and Nema V. (20180328). PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis. : Annals of clinical microbiology and antimicrobials.

MLA

Gupta Anamika, Pal Sudhir K, Pandey Divya, Fakir Najneen A, Rathod Sunita, Sinha Dhiraj, SivaKumar S, Sinha Pallavi, Periera Mycal, Balgam Shilpa, Sekar Gomathi, UmaDevi K R, Anupurba Shampa and Nema Vijay. PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis. : Annals of clinical microbiology and antimicrobials. 20180328.